The New York Times reported about a Centers for Medicare & Medicaid Services proposal to limit Medicare coverage for certain classes of drugs, including immunosuppressant medications. The article quotes Emily Shetty, LLS’s senior director of federal legislative affairs, who shares LLS’s concerns about the impact on patient access to care for Medicare beneficiaries.
Click here to read the article.
(LLS's Emily Shetty - picture right. Photo courtesy of New York Times.)